This Year Again, John Rim, CEO of Samsung Biologics, Emphasizes 'Customer Satisfaction Management'

Samsung Biologics has selected '4E (Excellence)'?which represents ▲Customer Satisfaction ▲Excellent Operational Efficiency ▲Top Quality ▲Outstanding Employee Capabilities?as the values to pursue this year, emphasizing to employees the importance of strengthening these areas.

John Rim, CEO of Samsung Biologics

Samsung Biologics recently announced on the 2nd that CEO John Rim sent a 'CEO Message' containing these points to employees. Rim stated, "Despite the slowdown in growth of the global pharmaceutical and bio markets due to the endemic (periodic resurgence of infectious diseases) last year and the economic downturn, our company achieved high sales growth and operating profit margins," adding, "I deeply appreciate the hard work of our employees who collaborated as one team across all fields to achieve today's results."

In his message, Rim encouraged employees by mentioning last year's key achievements, including ▲full operation of Plant 4 and groundbreaking of Plant 5 ▲securing 14 out of the top 20 global pharmaceutical companies as clients ▲launching new development platforms 'S-CHOsient' and 'S-Glyn' ▲receiving the Presidential Award for Sustainable Management contributions.

He continued, "As we face numerous challenges preparing for another decade of our company, global competition will intensify this year," emphasizing the 4E values that all employees should pursue together in 2024: ▲Customer Satisfaction as 'Customer Excellence' ▲Excellent Operational Efficiency as 'Operation Excellence' ▲Pursuit of Top Quality as 'Quality Excellence' ▲Outstanding Employee Capabilities as 'People Excellence.'

Rim said, “A company’s competitiveness is differentiated not only by technology, products, and human resources but also by customer satisfaction management based on trust with customers,” adding, “We must have a customer-oriented mindset that thoroughly prioritizes customers.” Regarding improving operational efficiency, he stated, “In 2024, we will focus on simplifying and standardizing organizations, tasks, and processes, and accelerate digital transformation.”

He also urged employees to devote even greater efforts to maximizing production efficiency and achieving a 100% batch (unit of pharmaceutical production) success rate. Rim emphasized, “Flawless quality management is a value that can never be overemphasized and is the foundation of our industry,” and requested, “Please approach your work with a responsible attitude, keeping in mind the patients who receive the biopharmaceuticals we produce, our customers who choose us, and your colleagues who work alongside you.”

Finally, Rim said, “At the heart of the company’s sustainable growth are all of you, our employees,” and expressed his hope that each person will continue learning and challenging themselves in their respective fields to grow into industry-leading experts. He also assured that the company will spare no support to strengthen employees’ capabilities and enhance work engagement.

This content was produced with the assistance of AI translation services.